|
|
|
Sanofi-Aventis Wants F.D.A. to Reconsider Heart Drug |
| Published at 16 May 2008, 01:10 GMT |
The company said it would resubmit its application for Multaq based on results from a study showing that the drug reduced both hospitalization and death in patients with atrial fibrillation. 
|
Nytimes.com news - Business |
| |
|
|
Receive our ezine for free and get
tips & advice on ebusiness.
LAST
ARTICLE
|
|
 |
| |
 |
 |
|
|
